Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis
Peter Rossing(Steno Diabetes Centers), Márcio Krakauer, Andrew E. Ajani, G. Levterov, Francis Duyck, Søren Rasmussen(Novo Nordisk (Denmark)), A. Wassermann, Shaobo Tan, Christophe De Block(University of Antwerp), Jean‐Pierre Salles, Kenneth W. Mahaffey(Cardiovascular Institute of the South), C. Vercammen, Katherine R. Tuttle(Providence Regional Medical Center Everett), V. Preumont, Roland E. Schmieder(Universitätsklinikum Erlangen), Z. Nikitov, Daniel Franco, Bilyana Stoyanovska-Elencheva, Richard Phoon, Kerr Pg, Corinne Debroye, Alicia Elbert, Richard E. Pratley(Translational Research Institute for Metabolism and Diabetes), Roza Bobeva, Zdravko Kamenov(Medical University of Sofia), Luís Henrique Santos Canani(Hospital de Clínicas de Porto Alegre), Heidrun Bosch‐Traberg(University of Copenhagen), Alejandro Chertkoff, Elizabeth Gelersztein, Andrea Da Porto, Gustavo Akerman Augusto, Robert S. Busch(Albany Medical Center Hospital), David Colquhoun, Vlado Perkovic(University of Copenhagen), A. Oviedo, J.M. Krzesinski, Amanda Mather(Royal North Shore Hospital), R. J. MacIsaac, S Roger, Johannes F. E. Mann(Universitätsklinikum Erlangen), Nicolas Belmar(Novo Nordisk (Denmark)), Thomas Idorn(University of Copenhagen), Miguel Ángel Quevedo, S. Gerilovska, Bruno Lapauw, N. Yabrudi, George L. Bakris(Pennsylvania State System of Higher Education)
Cited by 16
Related Papers
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|Hypertension|2003|13.3k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k